Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Rosenzweig-Lipson

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Psychopharmacology|June 8, 2010
Discriminative stimulus effects of serotonin agonists, neutral antagonists, and inverse agonists in pigeons: perspectives on intrinsic efficacy measurements in vivoMartilias Farrell, Sharon Rosenzweig-Lipson, Ellen Walker
Drug News & Perspectives|January 8, 2008
5-HT2C receptor agonists as an innovative approach for psychiatric disordersSharon Rosenzweig-Lipson, John Dunlop, Karen L Marquis
Neuropharmacology|June 27, 2012
Selective GABA(A) α5 positive allosteric modulators improve cognitive function in aged rats with memory impairmentMing Teng Koh, Sharon Rosenzweig-Lipson, Michela Gallagher
Psychopharmacology|September 18, 2007
A novel approach for predicting antidepressant-induced sexual dysfunction in ratsStacey J Sukoff Rizzo, Lee E Schechter, Sharon Rosenzweig-Lipson
Schizophrenia Research|June 22, 2017
Treatment with levetiracetam improves cognition in a ketamine rat model of schizophreniaMing Teng Koh, Yi Shao, Sharon Rosenzweig-Lipson, et al.
Current Protocols in Neuroscience|April 23, 2008
Schedule-induced polydipsia: a rat model of obsessive-compulsive disorderBrian Platt, Chad E Beyer, Lee E Schechter, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersArnold Bakker, Marilyn S S Albert, Sharon Rosenzweig-Lipson, et al.
European Journal of Pharmacology|May 23, 2006
Alpha 2A-adrenoceptors enhance the serotonergic effects of fluoxetineChad E Beyer, Qian Lin, Sharon Rosenzweig-Lipson, et al.
Behavioural Brain Research|January 15, 2008
The 5-HT(2C) receptor agonist WAY-163909 decreases impulsivity in the 5-choice serial reaction time testRachel Navarra, Thomas A Comery, Radka Graf, et al.
Handbook of Experimental Pharmacology|October 3, 2012
5-HT(2C) agonists as therapeutics for the treatment of schizophreniaSharon Rosenzweig-Lipson, Thomas A Comery, Karen L Marquis, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Psychopharmacology|June 8, 2010
Discriminative stimulus effects of serotonin agonists, neutral antagonists, and inverse agonists in pigeons: perspectives on intrinsic efficacy measurements in vivoMartilias Farrell, Sharon Rosenzweig-Lipson, Ellen Walker
Drug News & Perspectives|January 8, 2008
5-HT2C receptor agonists as an innovative approach for psychiatric disordersSharon Rosenzweig-Lipson, John Dunlop, Karen L Marquis
Neuropharmacology|June 27, 2012
Selective GABA(A) α5 positive allosteric modulators improve cognitive function in aged rats with memory impairmentMing Teng Koh, Sharon Rosenzweig-Lipson, Michela Gallagher
Psychopharmacology|September 18, 2007
A novel approach for predicting antidepressant-induced sexual dysfunction in ratsStacey J Sukoff Rizzo, Lee E Schechter, Sharon Rosenzweig-Lipson
Schizophrenia Research|June 22, 2017
Treatment with levetiracetam improves cognition in a ketamine rat model of schizophreniaMing Teng Koh, Yi Shao, Sharon Rosenzweig-Lipson, et al.
Current Protocols in Neuroscience|April 23, 2008
Schedule-induced polydipsia: a rat model of obsessive-compulsive disorderBrian Platt, Chad E Beyer, Lee E Schechter, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersArnold Bakker, Marilyn S S Albert, Sharon Rosenzweig-Lipson, et al.
European Journal of Pharmacology|May 23, 2006
Alpha 2A-adrenoceptors enhance the serotonergic effects of fluoxetineChad E Beyer, Qian Lin, Sharon Rosenzweig-Lipson, et al.
Behavioural Brain Research|January 15, 2008
The 5-HT(2C) receptor agonist WAY-163909 decreases impulsivity in the 5-choice serial reaction time testRachel Navarra, Thomas A Comery, Radka Graf, et al.
Handbook of Experimental Pharmacology|October 3, 2012
5-HT(2C) agonists as therapeutics for the treatment of schizophreniaSharon Rosenzweig-Lipson, Thomas A Comery, Karen L Marquis, et al.
Pageof 6